These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 26641079)

  • 21. Primary sclerosing cholangitis-associated cholangiocarcinoma: special considerations and best practices.
    Fung BM; Tabibian JH
    Expert Rev Gastroenterol Hepatol; 2021 May; 15(5):487-496. PubMed ID: 33682586
    [No Abstract]   [Full Text] [Related]  

  • 22. Neoplastic Transformation of the Peribiliary Stem Cell Niche in Cholangiocarcinoma Arisen in Primary Sclerosing Cholangitis.
    Carpino G; Cardinale V; Folseraas T; Overi D; Grzyb K; Costantini D; Berloco PB; Di Matteo S; Karlsen TH; Alvaro D; Gaudio E
    Hepatology; 2019 Feb; 69(2):622-638. PubMed ID: 30102768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic and epigenetic abnormalities in primary sclerosing cholangitis-associated cholangiocarcinoma.
    Timmer MR; Beuers U; Fockens P; Ponsioen CY; Rauws EA; Wang KK; Krishnadath KK
    Inflamm Bowel Dis; 2013 Jul; 19(8):1789-97. PubMed ID: 23615529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary sclerosing cholangitis.
    Milkiewicz P; Wunsch E
    Recent Results Cancer Res; 2011; 185():117-33. PubMed ID: 21822823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of hepato-pancreato-biliary cancer is increased by primary sclerosing cholangitis in patients with inflammatory bowel disease: A population-based cohort study.
    Yu J; Refsum E; Helsingen LM; Folseraas T; Ploner A; Wieszczy P; Barua I; Jodal HC; Melum E; Løberg M; Blom J; Bretthauer M; Adami HO; Kalager M; Ye W
    United European Gastroenterol J; 2022 Mar; 10(2):212-224. PubMed ID: 35107865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary sclerosing cholangitis: diagnosis, prognosis, and management.
    Singh S; Talwalkar JA
    Clin Gastroenterol Hepatol; 2013 Aug; 11(8):898-907. PubMed ID: 23454027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer risk in primary sclerosing cholangitis: Epidemiology, prevention, and surveillance strategies.
    Fung BM; Lindor KD; Tabibian JH
    World J Gastroenterol; 2019 Feb; 25(6):659-671. PubMed ID: 30783370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Duration of Inflammatory Bowel Disease Is Associated With Increased Risk of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis and IBD.
    Gulamhusein AF; Eaton JE; Tabibian JH; Atkinson EJ; Juran BD; Lazaridis KN
    Am J Gastroenterol; 2016 May; 111(5):705-11. PubMed ID: 27002801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of primary sclerosing cholangitis.
    Björnsson E
    Minerva Gastroenterol Dietol; 2009 Jun; 55(2):163-72. PubMed ID: 19305376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis of cholangiocarcinoma in primary sclerosing cholangitis.
    Taghavi SA; Eshraghian A; Niknam R; Sivandzadeh GR; Bagheri Lankarani K
    Expert Rev Gastroenterol Hepatol; 2018 Jun; 12(6):575-584. PubMed ID: 29781738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Detection of Cholangiocarcinoma in Primary Sclerosing Cholangitis Patients: Single Center Experience.
    Kuzu UB; Ödemiş B; Suna N; Yıldız H; Parlak E; Dişibeyaz S; Torun S; Akpınar MY; Coşkun O; Turhan N; Yüksel M; Kayaçetin E
    J Gastrointest Cancer; 2016 Mar; 47(1):8-14. PubMed ID: 26537791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatobiliary and extra-hepatic malignancies in primary sclerosing cholangitis.
    Bergquist A; Broomé U
    Best Pract Res Clin Gastroenterol; 2001 Aug; 15(4):643-56. PubMed ID: 11492973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inflammatory bowel disease with primary sclerosing cholangitis: A Danish population-based cohort study 1977-2011.
    Sørensen JØ; Nielsen OH; Andersson M; Ainsworth MA; Ytting H; Bélard E; Jess T
    Liver Int; 2018 Mar; 38(3):532-541. PubMed ID: 28796371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study.
    Bergquist A; Glaumann H; Persson B; Broomé U
    Hepatology; 1998 Feb; 27(2):311-6. PubMed ID: 9462625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In primary sclerosing cholangitis, gallbladder polyps are frequently malignant.
    Buckles DC; Lindor KD; Larusso NF; Petrovic LM; Gores GJ
    Am J Gastroenterol; 2002 May; 97(5):1138-42. PubMed ID: 12014717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent insights in primary sclerosing cholangitis.
    Ponsioen CY
    J Dig Dis; 2012 Jul; 13(7):337-41. PubMed ID: 22713082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A case of concomitant colitic cancer and intrahepatic cholangiocarcinoma during follow-up for ulcerative colitis.
    Tsuchiya K; Nanashima A; Ikeda T; Minami S; Nagano M; Hamada T; Yano K; Fujii Y
    Clin J Gastroenterol; 2017 Apr; 10(2):157-162. PubMed ID: 28138905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis.
    de Vries AB; Janse M; Blokzijl H; Weersma RK
    World J Gastroenterol; 2015 Feb; 21(6):1956-71. PubMed ID: 25684965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. More right-sided IBD-associated colorectal cancer in patients with primary sclerosing cholangitis.
    Claessen MM; Lutgens MW; van Buuren HR; Oldenburg B; Stokkers PC; van der Woude CJ; Hommes DW; de Jong DJ; Dijkstra G; van Bodegraven AA; Siersema PD; Vleggaar FP
    Inflamm Bowel Dis; 2009 Sep; 15(9):1331-6. PubMed ID: 19229982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential.
    Broomé U; Löfberg R; Veress B; Eriksson LS
    Hepatology; 1995 Nov; 22(5):1404-8. PubMed ID: 7590655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.